SOURCE: Healtheuniverse

September 12, 2005 09:15 ET

Healtheuniverse Establishes the Institute of Healtheliving to Further Research and Commercialization of Regenerative Cell Technologies

COVINA, CA -- (MARKET WIRE) -- September 12, 2005 -- Healtheuniverse, Inc. (OTC: HLUN), a biotechnology development firm specializing in the development and commercialization of biopharmaceutical and biomedical products, announced today the establishment of The Institute of Healtheliving. The Institute is focused on research, development and commercialization of regenerative medicine and cell technologies. Cell therapy systems for the regeneration and repair of damaged tissues have been initiated for the development of treatments for patients using regenerative cell technology. The clinical applications include tissue repair regeneration, bone regeneration, wound healing, and cosmetic and reconstructive surgery.

Vipul Dev M.D., Chief Executive Officer of Healtheuniverse, Inc., stated, "Our foundation and future is based on basic and sound scientific principles that have been engineered and perfected by our core group of medical scientists. It is through this emerging technology that we will soon be at the forefront of stem cell research and its application to the world of medicine and anti-aging."

Cells capable of regenerating organs and tissues are the cornerstone of regenerative medicine-based treatments. The scientific and medical communities have now accepted that there are regenerative cells in each of us that can be therapeutically useful. The Institute believes we can harness the body's own regenerative ability by designing novel products and systems that will facilitate and encourage healing by the body's natural repair components.

About Healtheuniverse, Inc.

HEALTHeUNIVERSE, Inc. is a biotechnology development firm specializing in the development and commercialization of Biopharmaceutical and Biomedical products. We develop and provide early stage project initiation, financing, product commercialization and development of patented and proprietary biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. More information on Healtheuniverse is available online at

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    Email Contact